GenEp

About GenEp

GenEp is a pre-clinical biotechnology company focused on developing novel therapeutic solutions based on proprietary genetic sequencing technologies. The company aims to address unmet medical needs by leveraging its intellectual property to advance drug discovery and development processes.

<problem> Drug discovery and development is often hindered by a limited understanding of the genetic factors influencing disease. Traditional therapeutic approaches may not effectively address the underlying genetic complexities of various conditions. </problem> <solution> GenEp is a pre-clinical biotechnology company that develops therapeutic solutions by applying proprietary genetic sequencing technologies to drug discovery. The company leverages its intellectual property to identify and target specific genetic markers associated with disease. By focusing on the genetic underpinnings of disease, GenEp aims to create more effective and personalized therapeutic interventions. </solution> <features> - Proprietary genetic sequencing technologies for identifying disease-related genetic markers - Targeted drug discovery and development processes - Focus on personalized therapeutic interventions </features> <target_audience> The primary target audience includes pharmaceutical companies and research institutions seeking novel therapeutic targets and advanced drug discovery platforms. </target_audience>

What does GenEp do?

GenEp is a pre-clinical biotechnology company focused on developing novel therapeutic solutions based on proprietary genetic sequencing technologies. The company aims to address unmet medical needs by leveraging its intellectual property to advance drug discovery and development processes.

Where is GenEp located?

GenEp is based in Charlottesville, United States.

When was GenEp founded?

GenEp was founded in 2021.

How much funding has GenEp raised?

GenEp has raised $9.0M.

Location
Charlottesville, United States
Founded
2021
Funding
$9.0M
Employees
1 employees
Investors
Angelini Ventures
G

GenEp

GenEp is a pre-clinical biotechnology company focused on developing novel therapeutic solutions based on proprietary genetic sequencing technologies. The company aims to address unmet medical needs by leveraging its intellectual property to advance drug discovery and development processes.

Charlottesville, United StatesFounded 2021110+ followers3/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.
Updated 3 months ago

Funding

$9.0M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Drug discovery and development is often hindered by a limited understanding of the genetic factors influencing disease. Traditional therapeutic approaches may not effectively address the underlying genetic complexities of various conditions.

Solution

GenEp is a pre-clinical biotechnology company that develops therapeutic solutions by applying proprietary genetic sequencing technologies to drug discovery. The company leverages its intellectual property to identify and target specific genetic markers associated with disease. By focusing on the genetic underpinnings of disease, GenEp aims to create more effective and personalized therapeutic interventions.

Target Audience

The primary target audience includes pharmaceutical companies and research institutions seeking novel therapeutic targets and advanced drug discovery platforms.

Features

  • Proprietary genetic sequencing technologies for identifying disease-related genetic markers
  • Targeted drug discovery and development processes
  • Focus on personalized therapeutic interventions
1
This profile is AI-generated and may contain inaccuracies.